Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,685 | 26,240 | 37,347 | 105,033 | 54,530 |
| Marketable Securities | 8,189 | 11,990 | 35,619 | 10,840 | 48,087 |
| Receivables | 2,778 | 173 | 2,131 | 1,026 | 2,233 |
| Inventories | N/A | N/A | 1,008 | 920 | 936 |
| Other current assets | 600 | 1,919 | 0 | 0 | 3,500 |
| TOTAL | $54,872 | $48,680 | $87,082 | $127,932 | $116,254 |
| Non-Current Assets | |||||
| PPE Net | 14,881 | 18,205 | 21,223 | 22,360 | 22,502 |
| Intangibles | 20,087 | 20,329 | 20,815 | 21,239 | 21,504 |
| Other Non-Current Assets | 12,919 | 12,599 | 12,894 | 13,465 | 13,908 |
| TOTAL | $47,887 | $51,133 | $54,932 | $57,064 | $57,914 |
| Total Assets | $102,759 | $99,813 | $142,014 | $184,996 | $174,168 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,131 | 29,282 | 1,207 | 1,382 | 1,491 |
| Accounts payable and accrued liabilities | 3,457 | 4,597 | 5,940 | 7,309 | 3,795 |
| Accrued Expenses | 14,176 | 15,734 | 22,300 | 25,020 | 23,622 |
| Other current liabilities | N/A | 1,817 | N/A | N/A | N/A |
| TOTAL | $60,145 | $51,814 | $29,832 | $34,119 | $29,505 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,411 | 4,320 | 30,880 | 30,176 | 5,104 |
| Deferred Revenues | 39,381 | 384 | 385 | 408 | 597 |
| Other Non-Current Liabilities | 190,099 | 190,099 | 190,099 | 190,099 | 190,099 |
| TOTAL | $197,685 | $195,540 | $222,198 | $221,585 | $196,382 |
| Total Liabilities | $257,830 | $247,354 | $252,030 | $255,704 | $225,887 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6 | 5 | 5 | 5 | 5 |
| Common Shares | 655,105 | 656,176 | 653,661 | 652,773 | 633,589 |
| Retained earnings | -806,595 | -798,091 | -761,916 | -722,784 | -679,247 |
| Other shareholders' equity | -3,581 | -5,626 | -1,761 | -697 | -6,061 |
| TOTAL | $-155,071 | $-147,541 | $-110,016 | $-70,708 | $-51,719 |
| Total Liabilities And Equity | $102,759 | $99,813 | $142,014 | $184,996 | $174,168 |